These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30979666)

  • 1. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT).
    Westman J; Eberhard J; Gaughran FP; Lundin L; Stenmark R; Edman G; Eriksson SV; Jedenius E; Rydell P; Overgaard K; Abrams D; Greenwood KE; Smith S; Ismail K; Murray R; Ösby U
    Schizophr Res; 2019 Jun; 208():138-144. PubMed ID: 30979666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT).
    Gaughran F; Stahl D; Ismail K; Greenwood K; Atakan Z; Gardner-Sood P; Stubbs B; Hopkins D; Patel A; Lally J; Lowe P; Arbuthnot M; Orr D; Corlett S; Eberhard J; David AS; Murray R; Smith S;
    BMC Psychiatry; 2017 Dec; 17(1):413. PubMed ID: 29284438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
    Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
    Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials.
    Bonfioli E; Berti L; Goss C; Muraro F; Burti L
    BMC Psychiatry; 2012 Jul; 12():78. PubMed ID: 22789023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.
    Heslin M; Patel A; Stahl D; Gardner-Sood P; Mushore M; Smith S; Greenwood K; Onagbesan O; O'Brien C; Fung C; Ohlsen R; Hopkins D; Lowe P; Arbuthnot M; Mutatsa S; Todd G; Kolliakou A; Lally J; Stubbs B; Ismail K; David A; Murray R; Atakan Z; Gaughran F
    BMC Psychiatry; 2017 Dec; 17(1):407. PubMed ID: 29273021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year efficacy of a lifestyle behavioural intervention on physical and mental health in people with severe mental disorders: results from a randomized controlled trial.
    Luciano M; Sampogna G; D'Ambrosio E; Rampino A; Amore M; Calcagno P; Rossi A; Rossi R; Carmassi C; Dell'Osso L; Bianciardi E; Siracusano A; Della Rocca B; Di Vincenzo M; ; Fiorillo A
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):903-915. PubMed ID: 37665401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
    Robinson DG; Schooler NR; Correll CU; John M; Kurian BT; Marcy P; Miller AL; Pipes R; Trivedi MH; Kane JM
    Am J Psychiatry; 2018 Feb; 175(2):169-179. PubMed ID: 28945118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychoeducation for overweight patients with psychiatric disorders: The Wellness program developed in Quebec].
    Provencher MD; Bélanger MÈ; Shriqui C; Lachance I; Bonneville S
    Encephale; 2016 Jun; 42(3):201-7. PubMed ID: 26924000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
    Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
    Trials; 2017 May; 18(1):233. PubMed ID: 28545578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study.
    Eack SM; Hogarty SS; Bangalore SS; Keshavan MS; Cornelius JR
    J Dual Diagn; 2016; 12(1):74-82. PubMed ID: 27089154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial.
    Pos K; Franke N; Smit F; Wijnen BFM; Staring ABP; Van der Gaag M; Meijer C; de Haan L; Velthorst E; Schirmbeck F
    J Consult Clin Psychol; 2019 Feb; 87(2):151-160. PubMed ID: 30570309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research.
    Gaspar PA; Castillo RI; Maturana A; Villar MJ; Ulloa K; González G; Ibaceta O; Ortiz A; Corral S; Mayol R; De Angel V; Aburto MB; Martínez A; Corcoran CM; Silva H
    Early Interv Psychiatry; 2019 Apr; 13(2):328-334. PubMed ID: 30548415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.
    Eack SM; Hogarty SS; Greenwald DP; Litschge MY; McKnight SA; Bangalore SS; Pogue-Geile MF; Keshavan MS; Cornelius JR
    Schizophr Res; 2015 Feb; 161(2-3):478-83. PubMed ID: 25510926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial.
    Gaughran F; Stahl D; Ismail K; Atakan Z; Lally J; Gardner-Sood P; Patel A; David A; Hopkins D; Harries B; Lowe P; Orr D; Arbuthnot M; Murray RM; Greenwood KE; Smith S
    BMC Psychiatry; 2013 Oct; 13():263. PubMed ID: 24131496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
    Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
    Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of lifestyle intervention strategies targeting weight outcomes in people with psychosis: a systematic review and network meta-analysis.
    Mucheru D; Hanlon MC; McEvoy M; Thakkinstian A; MacDonald-Wicks L
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1770-1825. PubMed ID: 31343494
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.